Stephen E. McRae, M.D.
Department of Interventional Radiology, Division of Diagnostic Imaging
About Dr. McRae
Dr. Stephen McRae joined MD Anderson in 2003 as an Assistant Professor in the Section of Interventional Radiology, Division of Diagnostic Imaging. He was appointed Fellowship Program Director in 2007 and was subsequently promoted to Associate Professor in 2011. Dr. McRae came to MD Anderson Cancer Center after completing his Clinical Fellowship in Vascular and Interventional Radiology at Northwestern University Medical School in Chicago, IL. Dr. McRae’s research interests are in percutaneous nonvascular interventions and patient education/outcomes respectively.
After being appointed Director of the Interventional Radiology Fellowship Program, Dr. McRae has devoted most of his time and effort to building a prestigious program which seeks to provide a unique focus on oncologic applications, while insuring a comprehensive interventional training experience through rotation partnerships with local academic and private hospitals.
Dr. McRae continues to work closely with the interventional department house staff to promote employee and patient education through such endeavors as publication of patient education videos, leading staff education efforts, and acting as the department liaison for faculty maintenance of certification.
Present Title & Affiliation
Primary Appointment
Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Diagnostic and Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX
Research Interests
Percutaneous non-vascular interventions and patient education/outcomes.
Education & Training
Degree-Granting Education
| 1997 | University of Virginia School of Medicine, Charlottesville, VA, USA, MD, Medicine |
| 1992 | Washington University, St. Louis, MO, USA, BA, Biology |
Postgraduate Training
| 2002-2003 | Clinical Fellowship, Vascular and Interventional Radiology, Northwestern University Medical School, Chicago, IL |
| 1998-2002 | Clinical Residency, Diagnostic Radiology, The University of Texas-Houston Medical School; The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1997-1998 | Clinical Internship, Transitional Medicine, Deaconess Hospital, St. Louis, MO |
Board Certifications
| 2005 | American Board of Radiology, Interventional Radiology/Diagnostic Radiology |
| 2002 | American Board of Radiology, Diagnostic Radiology |
Experience & Service
Academic Appointments
Associate Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2019
Associate Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2013
Assistant Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2003 - 2011
Administrative Appointments/Responsibilities
Education Director (Department level), Department of Diagnostic Radiology, MD Anderson Cancer Center- Interventional Radiology, Houston, TX, 2015 - 2020
Fellowship Program Director, Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2020
Institutional Committee Activities
Voting Member, Credentials Committees for the Medical Staff (MD Anderson), 2017 - Present
Member, Graduate Medical Education Finance Subcommittee, 2008 - Present
Member, Graduate Medical Education Committee, 2006 - Present
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Chang JY, Mehran RJ, Feng L, Verma V, Liao Z, Welsh JW, Lin SH, O'Reilly MS, Jeter MD, Balter PA, McRae SE, Berry D, Heymach JV, Roth JA, STARS Lung Cancer Trials Group. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery. Lancet Oncol 22(10):1448-1457, 2021. e-Pub 2021. PMID: 34529930.
- Gregg JR, Borregales LD, Choi H, Lozano M, McRae SE, Venkatesan AM, Davis JW, Nogueras-Gonzalez GM, Pisters LL, Ward JF. Prospective trial of regional (hockey-stick) prostate cryoablation: oncologic and quality of life outcomes. World J Urol 39(9):3259–3264, 2021. e-Pub 2021. PMID: 33454813.
- Westphalen AC, McCulloch CE, Anaokar JM, Arora S, Barashi NS, Barentsz JO, Bathala TK, Bittencourt LK, Booker MT, Braxton VG, Carroll PR, Casalino DD, Chang SD, Coakley FV, Dhatt R, Eberhardt SC, Foster BR, Froemming AT, Fütterer JJ, Ganeshan DM, Gertner MR, Mankowski Gettle L, Ghai S, Gupta RT, Hahn ME, Houshyar R, Kim C, Kim CK, Lall C, Margolis DJA, McRae SE, Oto A, Parsons RB, Patel NU, Pinto PA, Polascik TJ, Spilseth B, Starcevich JB, Tammisetti VS, Taneja SS, Turkbey B, Verma S, Ward JF, Warlick CA, Weinberger AR, Yu J, Zagoria RJ, Rosenkrantz AB. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology 296(1):76-84, 2020. e-Pub 2020. PMID: 32315265.
- Altok M, Kim B, Patel BB, Shih YT, Ward JF, McRae SE, Chapin BF, Pisters LL, Pettaway CA, Kim J, Demirel HC, Davis JW. Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research. Prostate Cancer Prostatic Dis 21(4):524-532, 2018. e-Pub 2018. PMID: 29988098.
- Gupta N, Patel A, Ensor J, Ahrar K, Ahrar J, Tam A, Odisio B, Huang S, Murthy R, Mahvash A, Avritscher R, McRae S, Sabir S, Wallace M, Matin S, Gupta S. Multiple Renal Artery Pseudoaneurysms in Patients Undergoing Renal Artery Embolization Following Partial Nephrectomy: Correlation with RENAL Nephrometry Scores. Cardiovasc Intervent Radiol 40(2):202-209, 2017. e-Pub 2016. PMID: 27681271.
- Ahrar JU, Gupta S, Ensor JE, Mahvash A, Sabir SH, Steele JR, McRae SE, Avritscher R, Huang SY, Odisio BC, Murthy R, Ahrar K, Wallace MJ, Tam AL. Efficacy of a Self-expanding Tract Sealant Device in the Reduction of Pneumothorax and Chest Tube Placement Rates After Percutaneous Lung Biopsy: A Matched Controlled Study Using Propensity Score Analysis. Cardiovasc Intervent Radiol 40(2):270-276, 2017. e-Pub 2016. PMID: 27826786.
- Abdelsalam ME, Mahvash A, Avritscher R, McRae SE, Odisio BC. Balloon-Assisted Flow Diversion and Selective Catheterization of Target Vessels for Hepatic Transarterial Embolization. J Vasc Interv Radiol 27(2):283-5, 2016. PMID: 26830942.
- Weksberg DC, Yang JN, Tam AL, Li J, Wang XA, Zhao Z, McRae SE, Settle SH, Rhines LD, Chang EL, Brown PD, Ghia AJ. Prospective validation of treatment accuracy using implanted fiducial markers for spinal stereotactic body radiation therapy. J Radiosurg SBRT 4(1):7-14, 2016. PMID: 29296421.
- Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, Groen HJ, McRae SE, Widder J, Feng L, van den Borne BE, Munsell MF, Hurkmans C, Berry DA, van Werkhoven E, Kresl JJ, Dingemans AM, Dawood O, Haasbeek CJ, Carpenter LS, De Jaeger K, Komaki R, Slotman BJ, Smit EF, Roth JA. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 16(6):630-7, 2015. e-Pub 2015. PMID: 25981812.
- Tsimberidou AM, Letourneau K, Fu S, Hong D, Naing A, Wheler J, Uehara C, McRae SE, Wen S, Kurzrock R. Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement. Cancer Chemother Pharmacol 68(1):247-53, 2011. e-Pub 2010. PMID: 20941597.
- Wallace MJ, Murthy R, Kamat PP, Moore T, Rao SH, Ensor J, Gupta S, Ahrar K, Madoff DC, McRae SE, Hicks ME. Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol 18(12):1500-7, 2007. PMID: 18057284.
- Kobayashi K, Gupta S, Trent JC, Vauthey JN, Krishnamurthy S, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, McRae SE, Hicks ME. Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors. Cancer 107(12):2833-41, 2006. PMID: 17096432.
- Wallace MJ, Choi E, McRae S, Madoff DC, Ahrar K, Pisters P. Superior mesenteric artery pseudoaneurysm following pancreaticoduodenectomy: Management by endovascular stent-graft placement and transluminal thrombin injection. Cardiovasc Intervent Radiol 30(3):518-22, 2006. PMID: 17031732.
- Gupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 104(8):1590-602, 2005. PMID: 16134179.
- Ahrar K, Himmerich JU, Herzog CE, Raymond AK, Wallace MJ, Gupta S, Madoff DC, Morello FA, Murthy R, McRae SE, Hicks ME. Percutaneous ultrasound-guided biopsy in the definitive diagnosis of osteosarcoma. J Vasc Interv Radiol 15(11):1329-33, 2004. PMID: 15525755.
- Kirk MM, Ransick A, McRae SE, Kirk DL. The relationship between cell size and cell fate in Volvox carteri. J Cell Biol 123(1):191-208, 1993. PMID: 8408198.
Abstracts
- Sabir S, Choi H, Ward J, Ahrar K, McRae SE,. Transgluteal MR-guided prostate biopsy: Results of a freehand technique in a closed 1.5T MRI. J Vasc Interv Radiol 24(4S):S176, 2013.
- Kuban JD, Philip AS, Chen GJ, Joseph Jr E, Tam A, Wallace MJ, Avritscher R, Ahrar JU, Ahrar K, Murthy R, Mahvash A, McRae SE, Gupta S. Effect of needle size on pneumothorax and chest tube placement rates in CT-guided percutaneous lung biopsies performed using a coaxial method: a large single-center study. J Vasc Interv Radiol Supplement 23(3S):S27-S28, 2012.
- Ahrar J, Gupta S, Ensor J, Ahrar K, Kumar M, Madoff DC, Wallace MJ, Murthy R, McRae S, Hicks ME. Response and survival after hepatic artery chemoembolization in patients with melanomas metastatic to the liver. J Vasc Interv Radiol 18(1):S57, 2007.
- Wallace MJ, Murthy R, Kamat P, Gupta S, Hicks ME, Ahrar K, Madoff DC, McRae S,. C-arm CT: Oncologic experience with hepatic arterial interventions. Radiological Society of North America Scientific Assembly and Annual Meeting Program 2006 (#SSC02-02). 92nd Radiological Society of North America Scientific Assembly and Annual Meeting, 2006.
- Kobayashi K, Gupta S, Trent J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, McRae S, Hicks ME. Hepatic artery chemoembolization in patients with metastatic gastrointestinal stromal tumors refractory to imatinib. J Vasc Interv Radiol(17):S77-78, 2006.
- Kobayashi K, Gupta S, Wallace MJ, Ahrar K, Madoff DC, Hicks ME, Murthy R, McRae S,. Preoperative transarterial embolization of hypervascular spinal tumors vascular anatomy, techniques and clinical outcomes {Abstract LL-NR4781}.In: Radiological Society of North America Scientific Assembly and Annual Meeting. 92nd Radiological Society of North America Scientific Assembly and Annual Meeting, 2006.
- Murthy R, Gupta S, Madoff DC, Nunez RF, Yao J, Szklaruk J, Ahrar K, Wallace MJ, McRae SE, Hicks ME. Feasibility of hepatic arterial therapy with yttrium-90 microspheres, SIR-spheres, in metastatic neuroendocrine neoplasia with hepatic dominant progression after failure of multiple systemic and hepatic artery therapies. 91st Radiological Society of North America Annual Meeting, 2005.
Book Chapters
- McRae, SE. Percutaneous Image-Guide Biopsy of the Pancreas. In: Digestive Disease Invertventions, 2018.
- Stafford RJ,McRae SE, Ahrar K. MRI-Guided Prostate Biopsy. In: Percutaneous Image Guided Biopsy. Springer Science+Business Media: New York, NY, 2013.
- Wallace MJ,McRae SE. Interventional radiology in the management of postoperative complications. In: Pancreatic Cancer. Jones and Bartlett, 345-355, 2005.
Grant & Contract Support
| Title: | Cellular and molecular biology |
| Funding Source: | NIH Research Grant |
| Role: | Principal Investigator |
| Title: | Utilization of a multimedia tool to improve communication, patient education and quality: A pilot study |
| Funding Source: | Mike Hogg Foundation |
| Role: | Principal Investigator |